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Abstract
Background: Cervical radicular syndrome (CRS) due to a herniated disc can be safely treated by surgical decompression
of the spinal root. In the vast majority of cases this relieves pain in the arm and restores function. However, conservative
treatment also has a high chance on relieving symptoms. The objective of the present study is to evaluate the (cost-)
effectiveness of surgery versus prolonged conservative care during one year of follow-up, and to evaluate the timing of
surgery. Predisposing factors in favour of one of the two treatments will be evaluated.
Methods/design: Patients with disabling radicular arm pain, suffering for at least 2 months, and an MRI-proven
herniated cervical disc will be randomised to receive either surgery or prolonged conservative care with surgery if
needed. The surgical intervention will be an anterior discectomy or a posterior foraminotomy that is carried out
according to usual care. Surgery will take place within 2–4 weeks after randomisation. Conservative care starts
immediately after randomisation. The primary outcome measure is the VAS for pain or tingling sensations in
the arm one year after randomisation. In addition, timing of surgery will be studied by correlating the primary
outcome to the duration of symptoms. Secondary outcome measures encompass quality of life, costs and perceived
recovery. Predefined prognostic factors will be evaluated. The total follow-up period will cover two years. A sample
size of 400 patients is needed. Statistical analysis will be performed using a linear mixed model which will be based
on the ‘intention to treat’ principle. In addition, a new CRS questionnaire for patients will be developed, the Leiden
Cervical Radicular Syndrome Functioning (LCRSF) scale.
Discussion: The outcome will contribute to better decision making for the treatment of cervical radicular syndrome.
Trial registration: NTR3504
Keywords: Cervical herniated disc, Cervical radicular syndrome, Anterior discectomy, Foraminotomy, Cost-effectiveness,
Conservative treatment, Randomized controlled trial, Shared decision making
Background
The cervical radicular syndrome (CRS) caused by a cer-
vical hernia nuclei pulposus (HNP), is a frequently oc-
curring problem with an incidence of 0.8 per 1000
inhabitants per year and a prevalence of 3.5 per 1000 in-
habitants [1,2]. CRS can lead to invalidating radicular
pain and may lead to motor and sensory deficits [1,3]. In
the majority of patients the symptoms gradually dimin-
ish within weeks to such an extent that normal daily ac-
tivities can be continued [4-6].
Many controversies exist regarding the timing of diag-
nostic procedures, the timing of referral of patients to
the neurologist or neurosurgeon and the timing of a sur-
gical intervention for a cervical HNP [7]. Nowadays, the
timing of an elective surgical intervention is not based
on scientific knowledge, but on the preference of the in-
dividual neurologist and neurosurgeon and local produc-
tion capacity.
A previous Dutch randomised controlled trial (RCT)
compared different conservative strategies in patients
with a short term CRS (at least 3 weeks pain in the arm).
In all strategy arms the median visual analogue scale (VAS)
pain in the arm decreased from 68–72 to 20–25 mm
(range 0–50 mm) within six months [6]. Moreover, indirect
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evidence indicates that most cervical disc protrusions re-
solve spontaneously without surgery [6,8-11]. If complaints
do not diminish spontaneously within reasonable time,
surgery can be considered. Surgical intervention is usually
performed by an anterior discectomy with subsequent an-
terior decompression of the spinal nerve. The effectiveness
(pain relief, satisfaction, muscle weakness improvement) of
the anterior discectomy to reduce symptoms is demon-
strated to be between 80 and 95%, and the procedure has
been established as a safe intervention [12-17]. Another
approach to decompress the spinal nerve is a posterior for-
aminotomy which has a positive outcome in 75 to 95% of
the cases [18]. Both conservative care and surgical inter-
vention are successful treatments, but it is unknown which
patients benefit most from each strategy [7-9,19]. Only two
small RCTs have been performed; Persson et al. demon-
strated that pain, function and mood after one year of
follow-up was equal in the conservative and surgical group
[20]. However, this was a small trial with 54 patients in the
conservative and 27 patients in the surgery group and the
power was estimated to be only 47%. Engquist et al. dem-
onstrated that a higher percentage of patients that were op-
erated (n = 31) rated their symptoms as ‘better’, than in the
conservatively treated group (n = 32). This difference disap-
peared at the two year evaluation moment [21]. In both
trials, timing of surgery was not studied, and no cost-
effectiveness or predisposing factors were evaluated. Fur-
thermore, two nonrandomised studies have been pub-
lished; in one study (n(surgery) = 39; n(conservative) = 21)
the outcomes were in favour of the conservative group
after 5.5 years [22] while the other study (n (surgery) = 51;
n (conservative) = 104) showed better results for the sur-
gery group after 1 year follow-up [23]. However, the surgi-
cal group in both studies had more pain and worse
functional scores at baseline, which excludes adequate out-
come comparison.
No studies have been published regarding the cost-
effectiveness of conservative and surgical therapy. In the
Netherlands, on average 2000 patients yearly receive sur-
gery for a cervical herniated disc, resulting in direct costs
of about €30 million per year. Although direct costs for
conservative care are lower, this group might have higher
indirect costs due to a longer period of reduced labour
productivity. Further research on cost-effectiveness could
lead to reduction of costs for healthcare and society.
The primary goal of the present study is to compare
the (cost-) effectiveness of conservative therapy for cervical
HNP, sometimes followed by ‘late’ surgery if needed, with
early surgical intervention. The timing of surgery will be
studied, and several predisposing factors will be analysed.
In addition to the trial, the participants will also participate
in the development and validation of an outcome scale for
CRS, the Leiden Cervical Radicular Syndrome Functioning
(LCRSF) scale.
Methods
Design
The present study is a multi-centre patient-randomised
controlled trial with parallel group design. The main
research question will be answered after one year of
follow-up and the complete follow-up will last two years.
The Medical Ethics Committee of the Leiden University
Medical Centre has approved the study protocol. Every
participating centre independently has given approval be-
fore including patients. Informed consent will be obtained
from all participating patients. The study was registered
July 3, 2012 in the Dutch Trial register (NTR3504).
Patients
All patients (18–75 yr.) with CRS and at least 2 months of
disabling pain or tingling sensations will be eligible for par-
ticipation. Either the VAS arm pain or the VAS tingling
sensations should be more than or equal to 40 mm. MRI
must confirm the presence of a herniated cervical disc as
explanation for the symptoms. The inclusion and exclusion
criteria are shown in Table 1.
Baseline data
The baseline questionnaires and demographics will be reg-
istered before randomisation. Also the preferences of pa-
tients and doctors will be registered using a 5-point scale
varying from ‘strong preference for surgery’ to ‘strong pref-
erence for conservative treatment’.
Randomisation procedure
A randomisation list is prepared for every participating
hospital. Randomisation will take place in variable per-
mutation blocks, which are unknown to the research
nurse. A random generator is used to generate the
Table 1 Inclusion and exclusion criteria
Inclusion criteria age 18–75 years
at least two months existing complaints of radicular
sensations in the arm (VAS arm pain or VAS tingling
sensations) of at least 40 mm
herniated disc with root compression confirmed by
MRI corresponding with the clinical symptoms
signed informed consent
Exclusion criteria paresis of MRC <4
mainly signs of myelopathy
any form of cervical spine surgery in the past
instability of the cervical spinal column requiring
stabilisation
pregnancy
insufficient knowledge of Dutch language
planned emigration in the year after randomisation
participation in another clinical trial
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random sequence within the blocks. The data manager,
who is not involved in the selection and allocation of pa-
tients, will prepare coded and sealed envelopes contain-
ing the treatment allocation based on the pre-generated
stratified random allocation list.
The research nurse will make an appointment with the
participant after the visit to the neurologist or neurosur-
geon. After registering baseline information, a sealed en-
velope with treatment allocation will be opened in front
of the patient. Patients who do not wish to be rando-
mised will be asked to participate in a cohort study, in
which both surgically and conservatively treated patients
will be followed.
Interventions
Group A: Surgical intervention
Surgery will take place within 2–4 weeks of randomisa-
tion. ‘Usual care’ will be pursued. Therefore the surgeon
can perform the surgery he prefers, with the exception
of implantation of an artificial disc. Variables of the pro-
cedure are filled in a standardised form.
For anterior discectomy, the level of surgery is verified
by fluoroscopy. The operation will be carried out by a
qualified neurosurgeon. Most surgeons operate using
loupe magnification. The platysma muscle is separated
or cleaved at the right side of the midline (less frequently
on the left side), and the prevertebral space is reached
by an approach medial to the sternocleidomastoid
muscle and the carotid artery, and lateral to the trachea
and oesophagus. The disc is incided and the corpora are
distracted. Discectomy is performed as thorough as pos-
sible. Regularly the posterior ligament is cut and the spinal
root is decompressed. If necessary, spondylarthrotic rims
are removed. To the preference of the surgeon bone graft
or an intervertebral fusion device is left behind. Decom-
pression of more levels is allowed. If the surgeon prefers
to decompress the cervical nerve root from the dorsal side
it is allowed to perform a dorsal foraminotomy. The mus-
cles of the neck are unilaterally detached at the site of
interest. With a high-speed drill a foraminotomy is per-
formed to decompress the nerve.
The postoperative care will be performed according to
‘usual care’ and will regularly be a stay in the hospital for
one or two days, without physiotherapeutic treatment.
If possible most patients will gradually return to work
within weeks after the surgical intervention.
Group B: Conservative management
Management of the conservative arm will be performed
according to usual care by either the neurologist or general
practitioner (GP). In the Netherlands, formal guidelines for
this approach are lacking, however, related guidelines for
lumbar radicular syndrome exist. The treatment of CRS is
aimed primarily at pain relief and maintenance/restoration
of normal day-to-day activities. Various studies have shown
that adequate and unambiguous information about the
problem from which the patient is suffering (the na-
ture of the condition) and what the patient can expect
(the prognosis), together with trustworthy counselling can
reduce the anxiety and uncertainty felt by the patients
Usually, no soft collar nor physiotherapy is prescribed,
however it is allowed. A graded activity time schedule is
made beforehand together with the patient [24,25].
In case of progressive neurological deficit or worsening
intolerable pain the GP or neurologist can refer the patient
back to the research nurse or neurosurgeon in order to
consider surgery. If, six months after randomisation, the
patient has still not improved or suffers from disabling
intermittent CRS, surgical treatment will be offered.
Outcome assessment
Non-blinded examinations by the research nurse will
take place at baseline, at 6 weeks, 3, 6, 9, 12, and
24 months after randomisation by visits and filling in
questionnaires (Table 2). In addition, the patients will
keep a diary. A second MRI will be made one year after
randomisation of which the outcome will be told after
the assessments. Data will be recorded and analysed at
the Data Coordination Centre in Leiden.
Primary outcome measure
The primary outcome parameter is severity of main
complaint: VAS pain or tingling sensations. The disab-
ling intensity in the arm will be measured with a
100 mm horizontal VAS; “no pain or tingling sensations”
at 0 mm and “the most terrible pain or tingling sensations
I can imagine” at 100 mm [26,27]. During each visit the
VAS arm pain will be scored. Additionally, the time of
complaints will be scored as the time between the first
general practitioners visit for this pain in the arm till the
moment of randomisation, measured in weeks.
Secondary outcome measures
1. Neck Disability Index (NDI). Although the NDI is a
score to monitor complaints of cervical myelopathy,
it gives a reliable impression of the disability of the
patient with respect to daily activities [28,29]. The
scores of the items are added up and transformed
into a scale of 0 to 100. A higher score reflects a
better health condition.
2. VAS pain or tingling sensations in the arm at
different time points (intake, 6 weeks and 3, 6, 8,
24 months).
3. VAS pain in the neck. The pain intensity in the neck
will be measured with a 100 mm horizontal VAS at
different time points (intake, 6 weeks and 3, 6, 8, 12,
24 months).
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4. Short Form-36 (SF-36). The SF-36 will be used as a
generic quality-of-life questionnaire. The questionnaire
relates to the analysis of the general functional status
of patients. The scores of the different topics are
added up and transformed into a scale of 0 to 100. A
higher score reflects a better health condition. The
different topics can be summarised in a physical and
psychological main domain.
5. Illness Perceptions Questionnaire – short form
(IPQ-K). The Brief Illness Perceptions Questionnaire
is translated from English to Dutch and adapted for
differences in culture [30]. This questionnaire
represents the way a patient copes with his complaints,
and it gives insight in the functioning of a patient.
6. Perceived recovery. To measure perceived recovery a
seven-point Likert scale will be used [31]. The scores
on this scale vary from ‘completely recovered’ to ‘worse
than ever’. The scales will be completed by the patient,
research nurse, and the neurologist or neurosurgeon.
7. Health state utility VAS. Patients will assess how
they value their health using a VAS ranging from
0 = as bad as death to 100 = perfect health.
8. DS-14. This Dutch questionnaire determines the
extent of ‘Distressed-personality’ of the patient. A
type D personality is defined in medical psychology
as the co-existent presence of both negative affectivity
(e.g. worrying, irritability, gloom) and social inhibition
(e.g. reticence and a lack of self-assurance). The
questionnaire consists of seven questions concerning
negative affectiveness and seven questions concerning
social inhibition. Individuals that score on both
dimensions 10 or higher are being classified as
having a type D personality. A type D personality has
been demonstrated to have a negative influence on
outcome of disease [32,33].
9. EuroQol – EQ-5D. The EuroQol (EQ-5D) will be
used to value the patients’ health for the cost utility
analysis. As indicated by the name the tool measures
five dimensions: mobility, self-care, daily activities,
pain/discomfort, and anxiety/depression. Each domain
is rated as having no problems, some problems or
extreme problems.
10. Cost diaries, including absenteeism, will be filled
out by the patients during follow-up.
11. MRI. MRI findings at baseline and after 1 year will be
compared: extrusion or protrusion, the difference in
size of the disc herniation, nerve root compression,
and, if operated, presence of scar tissue will be
registered. The data will be registered using
standardised CRFs, which will be filled out by the
local radiologist and neurosurgeon.
12. Frequency of (re)operation in the conservative group
and frequency of reoperation in the surgery group.
13. Frequency of complications.
Sample size
For the primary research question, the sample size is
based on the standard deviation of VAS arm pain, which
is estimated between 25 and 30, as reported by Persson
after 1 year of follow-up [20]. If we consider an α = 0.05
and a power of 90%, and we take 15 mm difference in VAS
pain in the arm as clinically relevant, then we need 100 pa-
tients in both groups (including a 10% compensation for
lost to follow-up) in a worst case scenario of a standard
Table 2 Follow-up flowchart
Intake Operation 6w 3 m 6 m 8 m 12 m 24 m
Demography & diagnosis X
Neurological examination X X x x x x
Informed consent X
MRI X x
NDI X x x x x x x
VAS pain/tinglings X x x x x x x
SF-36 X x x x x x x
IPQ-K X
Perceived recovery X x x x x x x
Health state utility VAS X x x x x x x
DS-14 X x x x x x x
EuroQol X x x x x x x
Diary X x x x x x x
Re-operation x x x x x x
Complication x x x x x x
Overview of follow-up moments and received information (for explanation: see text).
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deviation of 30 to show such a difference as statistically sig-
nificant under the null hypothesis. Because the analysis for
the secondary question requires more patients than the
primary research question, the sample size is chosen with
regard to the secondary research question. In order to in-
vestigate the modifying effect of the (pre-randomisation)
duration of pain (X, in months) on the treatment effect (T)
a covariance-analysis will be performed with the VAS mea-
sured after 12 months follow-up as a dependent variable
and T, X and the interaction T*X as independent vari-
ables. The coefficient of T*X represents the increase
(or decrease) of the treatment effect per month dur-
ation of pain on baseline. The standard error of the
slope of this regression line is
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1−ρ2ð Þp σvas=
ﬃﬃﬃﬃﬃﬃﬃﬃ
n−1
p
σx
 
, in
which ρ is the correlation between the duration of pain at
baseline and the VAS after 12 months follow-up, σVAS the
SD of the VAS after 12 months follow-up and σX the SD of
the duration of pain at baseline. Based on the RCT
by Persson [20] the σVAS is estimated conservatively at
30 mm and the SD of the duration of pain at baseline con-
servatively at 25. We are not informed about the correl-
ation, but ρ = 0 leads to a conservative estimate of the
standard error of the slope. Because this correlation is
probably small, the overestimation of the sample size is
probably limited (for instance 1% if ρ = 0.1 or 4% if
ρ = 0.20). The number of patients needed for a power
1-β = 0.80 and two-sided significance level of α = 0.05 can
be calculated as npergroup−1 ¼ 1:96þ 0:84ð Þ2⋅2σ2=Δ2 , in
which σ = σVAS/σX and Δ is the increase of the difference
in slope per month. An increase in the difference in
slope of 4 mm per year duration of pain at baseline is
considered as clinically relevant. According to the for-
mula above, 200 patients per study arm are needed,
adding up to a total of 400 patients.
The number of 200 patients in both groups that is
needed for the second primary research question also
has the advantage that it adds some additional power for
subgroup analyses. By taking 200 patients per group the
power for the first research question rises to above 99%
for a SD of 30 and a difference of 15.
Statistical analysis
All base case analyses will be performed based on the
‘intention to treat’ principle. Analysis will however, also
be performed based on a ‘as treated’ analysis.
Primary outcome
A linear mixed model will be used for the primary out-
come measure VAS pain/ tingling sensations in the arm.
Covariates in the model will be time as categorical, treat-
ment and the interaction between time and treatment.
The covariance model will be unstructured. The main
endpoint parameter, the difference between the two arms
at 1 year, will be estimated from this model. To answer the
question whether the difference in effect between surgical
and conservative treatment depends on de duration of
complaints, this linear mixed model will be extended with
extra (interaction) terms.
Secondary outcome
Secondary outcomes will be analysed for differences be-
tween groups with linear mixed models similar to the main
endpoint. Furthermore, we will investigate whether poten-
tial prognostic variables (gender, age, presence of neck
pain, more neck pain than arm pain, Valsalva manoeuvre
test, Spurling test, shoulder abduction test, type of person-
ality based on DS-14 and based on IPQ-K, anterior or pos-
terior approach, smoking, neurological deficits (strength
on an 1–5 Medical Research Council (MRC) scale and
sensibility), duration of the symptoms, Quetelet index) are
associated with the difference between the treatment arms
in the primary endpoint. This will be carried out by adding
a potential prognostic variable and its interaction with the
treatment arm to the linear mixed model.
Cost-effectiveness
The economic evaluation will be a cost-utility analysis
from a societal perspective, based on patient reports and
with a 1-year time horizon (without discounting). The
analysis will be very similar to the analysis performed for
the lumbosacral radicular syndrome [34].
Group averages will be compared using double-sided
bootstrapping and costs will be compared to patient out-
come using net-benefit analysis. An integral cost–price
analysis will be performed to estimate operating costs.
Other health care costs will be valued using standard
prices [35], including time and travel costs. Absenteeism
will be valued using both the friction-cost method (primary
analysis) and the human-capital method. Quality-adjusted
life years (QALYs) will be estimated using the EQ5D (pri-
mary analysis, Dutch tariff), the SF6D and the patients’
health state utility VAS (transformed to a utility scale using
the power transformation U = 1-(1-VAS/100)1.61) [36].
Development CRS questionnaire
The participants will also participate in the development
and validation of a functioning scale for CRS: the Leiden
Cervical Radicular Syndrome Functioning (LCRSF) scale.
This questionnaire will combine arm pain, neck pain,
and motor and sensory deficits. A secondary aim is to
build a prediction model predicting SF-6D and EQ-5D
utilities from the LCRSF scale.
Timeline
Ethics approval was obtained in May 2012 from the Hu-
man Research Ethics Committee of the Leiden University
Medical Center. Approval from the participating hospitals
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occurred during May 2012 – now. Recruitment of partici-
pants commenced in August 2012. All participants are
expected to have completed the study by the summer of
2016.
Conclusion and Discussion
The objective of the current trial is to study the ef-
fectiveness of the surgical intervention and prolonged
conservative care for CRS. Secondary, an analysis of cost-
effectiveness, timing of surgery and prognostic factors in
favour of one of the strategy arms will be performed. The
only two other randomised trials on this subject enrolled a
limited number of patients and did not measure these sec-
ondary outcomes.
The CASINO trial is performed using ‘usual care’ and
has a pragmatic design. It acknowledges that sometimes
it may not be possible to postpone surgery for every
conservative care patient until 6 months after allocation
and that some patients will recover before surgery is per-
formed in the surgical group. In these cases we consider
it infeasible and unethical to hold on to the randomised
treatment. Because of the intent-to-treat analysis, these
cases will be analysed according to the originally allo-
cated randomisation arm. Methodologically, this is the
appropriate way to compare two healthcare strategies, as
opposed to two treatments.
We hypothesise that prolonged conservative care will
have comparable results as surgery on primary outcome
(i.e. VAS pain or tingling sensations) after one year of
follow-up. However, due to the risks and the costs of sur-
gery we hypothesise that prolonged conservative care will
be more (cost-) effective with less adverse events.
We hypothesise that those patients who endured
symptoms for a longer time, would benefit from surgery.
If true, it would be interesting to investigate whether
there is a cut-off time-point after which surgery demon-
strates a better result.
Finally, the predefined subgroup analyses may provide
us with parameters, which can predict preference for
one of the two treatment strategies. It is hypothesised
that patients demonstrating more neck pain than arm
pain or a type D personality will have better outcomes
with conservative therapy.
The results of the present study will provide insight in
the results of surgery at an early phase and of prolonged
conservative care. This information will be useful in
shared decision-making for choosing the most appropri-
ate treatment for radicular cervical syndrome.
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